Clinical trial NCT03979833 - References

Von Hippel-Lindau Disease — Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Citation(s)

•   Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH
  Integra Foundation Award: Long-term natural history of hemangioblastomas in Von Hippel-Lindau disease: implications for treatment. Clin Neurosurg. 2006;53:324-31.
•   Fearon ER, Vogelstein B
  A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759-67. Review.
•   Fisher R, Horswell S, Rowan A, Salm MP, de Bruin EC, Gulati S, McGranahan N, Stares M, Gerlinger M, Varela I, Crockford A, Favero F, Quidville V, André F, Navas C, Grönroos E, Nicol D, Hazell S, Hrouda D, O'Brien T, Matthews N, Phillimore B, Begum S, Rabinowitz A, Biggs J, Bates PA, McDonald NQ, Stamp G, Spencer-Dene B, Hsieh JJ, Xu J, Pickering L, Gore M, Larkin J, Swanton C
  Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution. Genome Biol. 2014 Aug 27;15(8):433. doi: 10.1186/s13059-014-0433-z.
•   Gläsker S, Klingler JH, Müller K, Würtenberger C, Hader C, Zentner J, Neumann HP, Velthoven VV
  Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease. Cent Eur Neurosurg. 2010 May;71(2):80-7. doi: 10.1055/s-0029-1234040. Epub 2010 Mar 12.
•   Gossage L, Eisen T, Maher ER
  VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 2015 Jan;15(1):55-64. doi: 10.1038/nrc3844. Review.
•   Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JMC, Papaemmanuil E, Brewer DS, Kallio HML, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O'Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC; ICGC Prostate Group, Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC, Bova GS
  The evolutionary history of lethal metastatic prostate cancer. Nature. 2015 Apr 16;520(7547):353-357. doi: 10.1038/nature14347. Epub 2015 Apr 1.
•   Hanahan D, Weinberg RA
  Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013. Review.
•   Hanahan D, Weinberg RA
  The hallmarks of cancer. Cell. 2000 Jan 7;100(1):57-70. Review.
•   Lemeta S, Jarmalaite S, Pylkkänen L, Böhling T, Husgafvel-Pursiainen K
  Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma. J Neuropathol Exp Neurol. 2007 Sep;66(9):860-7.
•   Maher ER, Neumann HP, Richard S
  von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011 Jun;19(6):617-23. doi: 10.1038/ejhg.2010.175. Epub 2011 Mar 9. Review.
•   Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH
  Genetic analysis of von Hippel-Lindau disease. Hum Mutat. 2010 May;31(5):521-37. doi: 10.1002/humu.21219.
•   Poulsen ML, Gimsing S, Kosteljanetz M, Møller HU, Brandt CA, Thomsen C, Bisgaard ML
  von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors. Genet Med. 2011 Dec;13(12):1032-41. doi: 10.1097/GIM.0b013e31822beab1.
•   Sun M, Monzon F, Zhou L et al
  Identification of molecular drivers of human hemangioblastoma. Conference abstract: The 11th International VHL Symposium 2014 . 23-10-2014.
•   Vortmeyer AO, Falke EA, Gläsker S, Li J, Oldfield EH
  Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms. Acta Neuropathol. 2013 Mar;125(3):333-50. doi: 10.1007/s00401-013-1091-z. Epub 2013 Feb 12. Review.
•   Vortmeyer AO, Tran MG, Zeng W, Gläsker S, Riley C, Tsokos M, Ikejiri B, Merrill MJ, Raffeld M, Zhuang Z, Lonser RR, Maxwell PH, Oldfield EH
  Evolution of VHL tumourigenesis in nerve root tissue. J Pathol. 2006 Nov;210(3):374-82.
•   Vortmeyer AO, Yuan Q, Lee YS, Zhuang Z, Oldfield EH
  Developmental effects of von Hippel-Lindau gene deficiency. Ann Neurol. 2004 May;55(5):721-8.
•   Wanebo JE, Lonser RR, Glenn GM, Oldfield EH
  The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003 Jan;98(1):82-94.
•   Zhou J, Wang J, Li N, Zhang X, Zhou H, Zhang R, Ma H, Zhou X
  Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Pathol Int. 2010 Jun;60(6):452-8. doi: 10.1111/j.1440-1827.2010.02540.x.

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Details for clinical trial NCT03979833